Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Renal Cell 24Kidney Neoplasms 10Neoplasms 9Carcinoma 6Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoma, Non-Small-Cell Lung 4Recurrence 3Neoplasm Metastasis 3Melanoma 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Lung Neoplasms 2Kidney Diseases 2Glioblastoma 2Carcinoma, Adenoid Cystic 2Breast Neoplasms 2Advanced Solid Tumors 2cT2a N0NxM0 Renal Tumor 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumors 1Solid Tumors 1Solid Malignancies 1Skin Neoplasms 1Sarcoma, Alveolar Soft Part 1Salivary Gland Neoplasms 1Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1Prostatic Neoplasms 1

Interventions

Everolimus 6pasireotide 5Octreotide 5lanreotide 2ganitumab 2cabozantinib 2Bevacizumab 2surufatinib 1nintedanib 1ibrutinib 1gallium Ga 68 dotatate 1fosbretabulin 1epothilone B 1conatumumab 1cixutumumab 1carfilzomib 1azaspirane 1arginyllysine 1aflibercept 1Temozolomide 1TKM-080301 1Sunitinib 1Sorafenib 1Somatostatin 1Random Allocation 1Ramucirumab 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoid Tumor × Axitinib × Clear all
NCT01435122 2018-10-02

A Study of Axitinib in Advanced Carcinoid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
30 enrolled 10 charts
Endocrine

Carcinoid Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡